MetaOptics buyback authority was approved by shareholders on October 28, 2026, giving the board flexibility to repurchase shares as the company works to deliver existing orders and develop new optical technology.

Key Takeaways

  • The mandate permits, but does not require, MetaOptics to buy back shares.
  • Existing Direct Laser Writer orders are scheduled for delivery by the end of 2026.
  • Testing of a 12-megapixel color imaging metalens is expected to begin in January 2027.

MetaOptics buyback gives board flexibility

Shareholders supported the share buyback mandate at an extraordinary general meeting on October 28. MetaOptics said the mandate gives its board a capital-management tool to acquire shares when appropriate and in the interests of the company and its shareholders.

The company said any future purchases would depend on factors including market conditions, its financial position, working capital needs and growth plans. Adoption of the mandate does not mean a repurchase has taken place.

Laser-writer orders and optical modules

MetaOptics said it remains on track to fulfill existing Direct Laser Writer purchase orders by the end of 2026. The company expects the deliveries to contribute positively to revenue for the financial year ending December 31, 2026.

The Direct Laser Writer platform is a tool for metalens fabrication and characterization, including prototyping and low-volume production.

The company also said it had secured a design and evaluation order from a major U.S. foundry customer for co-packaged optics modules incorporating its metalens technology. The modules are expected to support ULED and laser-based configurations.

Metalens testing planned for 2027

MetaOptics said it had completed validation of the design and fabrication processes for a 12-megapixel color imaging titanium dioxide metalens. Production and fabrication on a 12-inch wafer were underway, with testing expected to start in January 2027.

Read More News

More FinanceVelix news

Disclaimer

This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.